Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Shapourzadeh A et al. | 2020 | intact cell/cell culture, adipose-derived stem cells | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 31.4–62.8 µT |
Kobbert C et al. | 2008 | intact cell/cell culture, bov-cSMC (bovine coronary smooth muscle cells), ms-aSMC (aortic smooth muscle cells from mice), and human endothelial cells | RF, magnetic field, low frequency, 50/60 Hz | 36 µT |
Ross SM | 1990 | intact cell/cell culture, rabbit-ligament fibroblast (RLF) cell line | magnetic field, low frequency, 50/60 Hz, DC, static magnetic field | 42–261 µT |
Mevissen M et al. | 1996 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, co-exposure | 50 µT |
Scarfi MR et al. | 1999 | intact cell/cell culture, human lymphocytes | magnetic field, 50/60 Hz | 0.05–1 mT |
Del Re B et al. | 2004 | bacterium, <i>Escherichia coli</i>/Lac Z<sup>-</sup> strain (transformed with a plasmid containing a Tn10 derivative element expressing beta-galactosidase only after transposition)) | magnetic field, low frequency, 50/60 Hz | 0.05–1 mT |
Capri M et al. | 2004 | intact cell/cell culture, human peripheral blood mononuclear cells | magnetic field, 50/60 Hz, co-exposure | 0.05–2.5 mT |
Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 60 µT |
Tonini R et al. | 2001 | intact cell/cell culture, NG108-15 cells (the cells result from the fusion of N18TG-2 mouse neuroblastoma cells with C6BU-1 rat glioma cells) | magnetic field, 50/60 Hz | 60–360 µT |
Katsir G et al. | 1998 | intact cell/cell culture, primary chick embryo fibroblasts | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.06–0.7 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.